American Well Corporation (AMWL)
NYSE: AMWL
· Real-Time Price · USD
6.25
-1.08 (-14.73%)
At close: May 01, 2025, 3:59 PM
6.65
6.49%
After-hours: May 01, 2025, 07:38 PM EDT
Company Description
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare.
The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings.
Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks.
American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
American Well Corporation

Country | United States |
IPO Date | Sep 17, 2020 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 877 |
CEO | Dr. Ido Schoenberg M.D. |
Contact Details
Address: 75 State Street Boston, Massachusetts United States | |
Website | https://amwell.com |
Stock Details
Ticker Symbol | AMWL |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001393584 |
CUSIP Number | 03044L204 |
ISIN Number | US03044L2043 |
Employer ID | 00-0000000 |
SIC Code | 7389 |
Key Executives
Name | Position |
---|---|
Dr. Ido Schoenberg M.D. | Chairman & Chief Executive Officer |
Amber Howe | Chief People Officer |
Anna Nesterova | Head of Legal |
Dan Zamansky | Chief Product & Technology Officer |
Dr. Cynthia Horner FAAFP, M.D. | Chief Medical Officer & President of Amwell Medical Group |
Dr. Roy Schoenberg M.D., M.P.H. | Executive Vice Chairman |
Paul Francis McNeice | Vice President of Accounting |
Phyllis I. Gotlib | President of Amwell International |
Sue Dooley | Head of Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 23, 2025 | ARS | Filing |
Apr 23, 2025 | DEFA14A | Filing |
Apr 23, 2025 | DEF 14A | Filing |
Apr 03, 2025 | 4 | Filing |
Apr 03, 2025 | 4 | Filing |
Mar 10, 2025 | 4 | Filing |
Mar 10, 2025 | 3 | Filing |
Mar 05, 2025 | 4 | Filing |
Mar 05, 2025 | 4 | Filing |
Mar 03, 2025 | 8-K | Current Report |